Naitive and Parvizi Surgical Partner to Advance Osteoporosis Detection
The collaboration supports development and clinical deployment of OsteoSight, technology designed for the early identification of low bone mineral density....
Nov 07, 2024,
Naitive and Parvizi Surgical Partner to Advance Osteoporosis Detection
Corin Gains FDA 510(k) Clearance for Icona Femoral Stem
The new collared, metaphyseal-filling, triple-taper stem was designed using comprehensive data from the CorinRegistry....
Nov 06, 2024,
Osteopore Enters Partnership with DKSH
The collaboration will promote Osteopore’s off-the-shelf products in Singapore for bone loss treatments in upper and lower extremities. ...
Nov 06, 2024,
SI-BONE Gains Pass-Through Payment Status for iFuse Bedrock Granite
TPT payment status allows patient access to new technology like Granite by providing an add-on payment to hospitals and ambulatory...
Nov 06, 2024,
Smith+Nephew Structural Improvements Offset by China Headwinds
The company's orthopedic sales grew in the mid-single digits but headwinds in China will have an ongoing impact into 2025....
Nov 06, 2024,
Orthopedic Companies Report Results from Third Quarter 2024
Stay up to date on the orthopedic market's 3Q performance in 2024 as we update this post with company sales...
Nov 06, 2024,
Anika Therapeutics Pivots to Leverage HA Expertise
The company declined in the mid-single digits during the third quarter of 2024 as it pivots away from Arthrosurface and...
Nov 05, 2024,
ATEC Shifts Gears, Focused on Cash Flow Breakeven
The company grew more than 27% in the third quarter of 2024 as it hones its focus on attaining cash...
Nov 05, 2024,
Zimmer Biomet’s ERP Issues Impact 2024 Outlook
The company grew in the mid-single digits in the third quarter of 2024 as it worked through ERP-related issues impacting...
Nov 04, 2024,
CONMED Adjusts Guidance Due to Hurricane Aftermath
The company's orthopedic sales grew nearly 5% in the third quarter of 2024 but hurricane impacts will impact fourth quarter...
Nov 04, 2024,
Loading new posts...
No more posts
